Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Malti Arya"'
Publikováno v:
Plasmonics. 18:955-969
Autor:
Poonam Parashar, Chandra Bhushan Tripathi, Malti Arya, Jovita Kanoujia, Mahendra Singh, Abhishek Yadav, Shubhini A. Saraf
Publikováno v:
Drug Delivery and Translational Research.
Autor:
Sapana Kushwaha, Priyanka Prajapati, Anand Kumar, Rishabh Chaudary, Shubhada Mangrulkar, Malti Arya
Publikováno v:
Current Molecular Pharmacology. 16
Background: As people age, physical impairments may have a deleterious role in skeletal muscles. Sarcopenia Clinical Practice Guidelines 2017 and the European Working Group on Sarcopenia in older people are two organizations that have published essen
Autor:
Malti Arya, Prakash Tiwari, Chandra Bhushan Tripathi, Poonam Parashar, Mahendra Singh, Priyam Sinha, Narayan P. Yadav, Gaurav Kaithwas, Krishna P. Gupta, Shubhini A. Saraf
Publikováno v:
Molecular Pharmaceutics. 19:1028-1030
Autor:
Malti Arya, Jovita Kanoujia, Mahendra Singh, Shubhini A. Saraf, Gaurav Kaithwas, Chandra Bhushan Tripathi, Poonam Parashar
Publikováno v:
Journal of Liposome Research. 30:21-36
Mammary gland tumour has the highest incidence rate and mortality in women, worldwide. The present study envisaged a molecularly targeted nanostructured lipid carrier (NLCs) for doxorubicin (Dox) delivery capable of inducing cellular apoptosis in mam
Publikováno v:
Journal of Drug Delivery Science and Technology. 49:219-226
Dementia defines wide-ranging symptoms related to a decline in memory or coherent thinking. The focused endeavor of the present study was to develop and assess the efficacy of rivastigmine hydrogen tartrate (RHT) loaded nanostructured lipid carrier (
Autor:
Shubhini A. Saraf, Poonam Parashar, Mahendra Singh, Chandra Bhushan Tripathi, Malti Arya, Gaurav Kaithwas, Jovita Kanoujia, Pooja Singh, Krishna P. Gupta, Anupam Guleria
Publikováno v:
Drug Delivery and Translational Research. 9:53-65
Phytic acid (PA) has momentous chemotherapeutic potential. Due to the chelate formation and rapid elimination, it is not popular in cancer treatment. The present work was inquested to develop a surface-modified nanoformulation of PA which prevents it
Autor:
Shailendra K. Saraf, Malti Arya, Jovita Kanoujia, Chandra Bhushan Tripathi, Mahendra Singh, Poonam Parashar, Vivek Ranjan Sinha, Shubhini A. Saraf
Publikováno v:
Drug Delivery and Translational Research. 8:591-601
The oral bioavailability of felodipine (FEL) is very low, i.e., about 15%. This could be due to low water solubility and hepatic first-pass effect. The objective of the present study was to develop FEL microemulsion-based gel, to bypass the first pas
Autor:
Poonam Parashar, Mahendra Singh, Chandra Bhushan Tripathi, Sudipta Saha, Jovita Kanoujia, Ashok K. Singh, Pranesh Kumar, Vinit Raj, Neha Gupta, Malti Arya, Shubhini A. Saraf
Publikováno v:
AAPS PharmSciTech. 19:1205-1218
The present study was undertaken to improve rosuvastatin (RSV) bioavailability and pharmacological response through formation of SNES using Perilla frutescens oil as lipid carrier. The composition of oil was estimated by fatty acid methyl ester (FAME
Autor:
Chandra Bhushan Tripathi, Vivek Ranjan Sinha, Mahendra Singh, Shailendra K. Saraf, Malti Arya, Shubhini A. Saraf, Jovita Kanoujia, Poonam Parashar
Publikováno v:
Drug Delivery and Translational Research. 8:204-225
The oral bioavailability of felodipine, a dihydropyridine calcium channel antagonist, is about 15%. This may be due to poor water solubility, and a lower intestinal permeability than a BCS class I drug, and hepatic first-pass metabolism of the drug.